Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ricklin

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Immunobiology|June 30, 2016
From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stageDimitrios C Mastellos, Edimara S Reis, Despina Yancopoulou, et al.
Journal of Molecular Recognition : JMR|August 7, 2009
Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatinPaola Magotti, Daniel Ricklin, Hongchang Qu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 6, 2013
Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantationIoannis Kourtzelis, Stavros Rafail, Robert A DeAngelis, et al.
Seminars in Immunology|March 30, 2016
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical applicationGeorge Hajishengallis, Evlambia Hajishengallis, Tetsuhiro Kajikawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2Daniel Ricklin, Salome K Ricklin-Lichtsteiner, Maciej M Markiewski, et al.
Science (New York, N.Y.)|January 6, 2011
Structures of C3b in complex with factors B and D give insight into complement convertase formationFederico Forneris, Daniel Ricklin, Jin Wu, et al.
Nature Immunology|June 9, 2009
Structure of complement fragment C3b-factor H and implications for host protection by complement regulatorsJin Wu, You-Qiang Wu, Daniel Ricklin, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2015
Applying complement therapeutics to rare diseasesEdimara S Reis, Dimitrios C Mastellos, Despina Yancopoulou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2012
C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assayEdimara S Reis, Hui Chen, Georgia Sfyroera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2012
Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonistToshiharu Abe, Kavita B Hosur, Evlambia Hajishengallis, et al.
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Immunobiology|June 30, 2016
From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stageDimitrios C Mastellos, Edimara S Reis, Despina Yancopoulou, et al.
Journal of Molecular Recognition : JMR|August 7, 2009
Structure-kinetic relationship analysis of the therapeutic complement inhibitor compstatinPaola Magotti, Daniel Ricklin, Hongchang Qu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 6, 2013
Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantationIoannis Kourtzelis, Stavros Rafail, Robert A DeAngelis, et al.
Seminars in Immunology|March 30, 2016
Complement inhibition in pre-clinical models of periodontitis and prospects for clinical applicationGeorge Hajishengallis, Evlambia Hajishengallis, Tetsuhiro Kajikawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2Daniel Ricklin, Salome K Ricklin-Lichtsteiner, Maciej M Markiewski, et al.
Science (New York, N.Y.)|January 6, 2011
Structures of C3b in complex with factors B and D give insight into complement convertase formationFederico Forneris, Daniel Ricklin, Jin Wu, et al.
Nature Immunology|June 9, 2009
Structure of complement fragment C3b-factor H and implications for host protection by complement regulatorsJin Wu, You-Qiang Wu, Daniel Ricklin, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2015
Applying complement therapeutics to rare diseasesEdimara S Reis, Dimitrios C Mastellos, Despina Yancopoulou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2012
C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assayEdimara S Reis, Hui Chen, Georgia Sfyroera, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2012
Local complement-targeted intervention in periodontitis: proof-of-concept using a C5a receptor (CD88) antagonistToshiharu Abe, Kavita B Hosur, Evlambia Hajishengallis, et al.
Pageof 14